Goal and symptom review
Clarify what you hope to address and whether it first requires diagnostic investigation.
Wellness / Peptides
Peptides deserve a medical conversation.
For adult women who want a clearer, more responsible discussion of peptide therapy than social media can provide.
The approach
Promising is not the same as proven.
“Peptide” describes a broad category, not a single treatment. Evidence, product quality, regulatory status, route, dosing, risks and appropriate monitoring vary considerably.
Dr Luhard's consultation focuses on the clinical question first. You will be told when evidence is limited, when a proposed use is off-label or unregistered, and when a more established option should take priority.
What we can discuss
Evidence and status
Discuss what is known, what remains uncertain and the regulatory status of a proposed therapy.
Risk and suitability
Consider medical history, medicines, allergies, pregnancy or breastfeeding status and potential contraindications.
Monitoring plan
If therapy is prescribed, agree on follow-up, relevant observations or tests and clear reasons to stop or escalate care.
No peptide is prescribed by web form
The form only requests a consultation. It is not a prescription, diagnosis or treatment order.
Peptide therapy consultations for adult women in Pretoria
Dr Luhard has a focused clinical and educational interest in peptides. Through MedBase, his work also includes practitioner education. FemaleHealth gives adult women a discreet route to discuss these therapies at Medify in Waterkloof.
Quality and traceability matter
Injectable or prescription treatment should come through lawful, clinically accountable channels with appropriate records and patient-specific instructions. FemaleHealth does not encourage self-sourcing or unsupervised use.
Questions
What women ask
There is no universally “best” peptide. The answer depends on the clinical question, evidence, legal availability, medical history and whether a peptide is appropriate at all.
Status differs by product and proposed use. The specific status and implications should be explained during the consultation.
Do not assume they are safe. Disclose pregnancy, breastfeeding and pregnancy plans. Treatment may be inappropriate because safety data are limited or risk is unacceptable.